Advanced Metabolic Reset

Advanced Metabolic Reset Research Bundle | Veyvora

What this page covers: how the three-pen bundle is composed, what each component is, where the evidence boundary sits for bundle-level claims, and how to confirm pricing and batch documentation before ordering.

Veyvora’s Advanced Metabolic Reset Research Bundle is a three-pen research stack combining MOTS-C + SS-31 40 mg, Retatrutide 40 mg, and NAD+ 1000 mg, sold as a bundled research purchase at a lower combined price than the three pens acquired separately (Veyvora, 2026) [4]. The bundle is available directly through Veyvora’s site; no verified bundle price was published in the live page content captured on 30 August 2026, so current pricing must be confirmed at checkout before ordering [4][5].

Confirm bundle availability and pricing at the Veyvora product page before ordering.

Veyvora describes the Advanced Metabolic Reset Research Bundle as “the triple agonist, mitochondrial blend and NAD+, the deepest reset in the range” [4][6]. The three pens act through complementary metabolic mechanisms; no combined-outcome data is published, and each pen also carries its own separate evidence base and COA [4][6]. Each pen ships with 10 × 31G 6 mm needles, a dosing card, and a certificate of analysis (COA) available on request [2][3].

The bundle is framed for in-vitro laboratory research use only. No bundle-level clinical or metabolic-outcome data is published by Veyvora; the component evidence remains separate for each pen [1][4].

Key Takeaways

• The bundle groups three distinct research pens, MOTS-C + SS-31 40 mg, Retatrutide 40 mg, and NAD+ 1000 mg, which act through complementary metabolic mechanisms; each retains its own separate evidence base.
• No bundle-specific experimental data exists; each component carries its own separate evidence base.
• Pricing was unverified in content captured on 30 August 2026 and must be confirmed at checkout.
• Retatrutide is a triple GLP-1/GIP/glucagon receptor agonist; MOTS-C + SS-31 is a mitochondrial-focused peptide blend; NAD+ (nicotinamide adenine dinucleotide) is a metabolic coenzyme, all supplied for in-vitro research only.
• Each pen ships with needles, a dosing card, and a COA available on request.

Bundle Identity and Composition

This three-pen research stack comprises MOTS-C + SS-31 40 mg, Retatrutide 40 mg, and NAD+ 1000 mg, sold as a bundled purchase at a lower combined price than the three pens acquired separately, positioned by Veyvora as “the triple agonist, mitochondrial blend and NAD+, the deepest reset in the range” (Veyvora, 2026) [4].

Each pen retains its own product identity, quantity, and evidence base; the three are combined here because they address complementary points in metabolic research, and no combined-outcome claim is made at bundle level [4][5].

No verified bundle price appeared in the live page content captured on 30 August 2026; confirm current pricing at checkout before ordering [4]. Stock availability should likewise be verified on the live product page [5].

Included Components

The Advanced Metabolic Reset Research Bundle contains three separately identified research pens, each with its own quantity, per-click dose, and product page; no combined formulation exists at bundle level [4][5].

Sources: Veyvora product pages, 30 August 2026 [2][3][4].

Each pen is sealed at dispatch and supplied with needles and a dosing card [2][3]. Retatrutide is a triple GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptor agonist investigated in published clinical literature; MOTS-C + SS-31 is a mitochondrial-focused peptide blend; NAD+ (nicotinamide adenine dinucleotide) is a metabolic coenzyme. All three are supplied for in-vitro laboratory research use only [1][4].

Researchers comparing incretin receptor coverage across investigational compounds can consult the retatrutide versus tirzepatide comparison.

Bundle-Level Evidence Boundary

No bundle-specific experimental data, clinical outcomes, or published studies examine the three components as a combined formulation [1][4][5]. The component-level framing on the live product pages reflects this: Retatrutide is described as a triple GLP-1/GIP/glucagon receptor agonist, MOTS-C + SS-31 as a mitochondrial-focused peptide blend, and NAD+ as a metabolic coenzyme, each addressing a complementary point in metabolic research and each with its own evidence base [1][4].

Published literature addresses each mechanism independently rather than in co-administration, so evidence for each component in isolation does not establish a combined effect. The mitochondrial research underpinning MOTS-c and SS-31 research and the coenzyme role documented in NAD+ research are separate bodies of work from the triple agonist literature on Retatrutide [1][6]. Each component should therefore be evaluated against its own evidence base.

Batch Documents and Handling

Each pen, covering MOTS-C + SS-31 40 mg, Retatrutide 40 mg, and NAD+ 1000 mg, ships with a COA available on request, confirming batch identity and assay documentation at the component level [2][3][4]. The live product pages do not publish batch-specific sterility data, endotoxin values, or cold-chain thresholds for the bundle as a grouped shipment; confirm any handling requirement beyond the manufacturer’s stated instructions directly before use [2][3][4].

Researchers can match a received pen to its published certificate using Veyvora’s verify your batch tool. Before drawing conclusions from purity figures, consult what HPLC purity does and doesn’t prove: HPLC (high-performance liquid chromatography), mass spectrometry, and endotoxin assay each measure distinct properties and do not collectively confirm every aspect of material performance [4].

Shipping and Storage Conditions

Shipping temperature, cold-chain packaging specification, and transit conditions for the bundle are not detailed in the current live content. Treat these as unverified until confirmed from a contemporaneous dispatch note or product page capture dated to the day of purchase [2][3][4]. Researchers requiring storage and handling instructions beyond the manufacturer’s stated guidance should consult Veyvora’s storage guidance for research peptides before dispatch is arranged.

Commercial Terms

Veyvora lists the Advanced Metabolic Reset Research Bundle as a bundled research purchase at a lower combined price than buying the three pens separately, because the grouped format reduces per-unit cost relative to individual checkout [1]. No verified GBP price, stock count, or shipping service-level agreement is available from the live content captured on 30 August 2026; confirm any specific figure directly from the live checkout flow before ordering [1]. Treat any third-party price reference as unverified unless independently captured from the Veyvora product page on the date of purchase, as pricing and availability change [1].

Research-Use-Only Limitations

Veyvora sells the Advanced Metabolic Reset Research Bundle strictly for laboratory and in-vitro research purposes; none of the three pens, MOTS-C + SS-31 40 mg, Retatrutide 40 mg, or NAD+ 1000 mg, are presented as medicines, supplements, or approved metabolic therapies [1][6]. Retatrutide, the triple GLP-1/GIP/glucagon agonist in the stack, remains investigational in current authoritative literature and had not been established as an approved therapeutic agent for any indication as of 30 August 2026 [1]. Attributing metabolic outcomes to the bundle, or framing any component as a treatment, overstates the available evidence.

Proceed to the Veyvora product page to verify current bundle availability and confirm batch documentation before dispatch.

Sources

[1] Metabolic Research Pens | Veyvora, veyvora.com, https://veyvora.com/categories/metabolic [2] MOTS-C + SS-31 40 mg Pen | Veyvora, veyvora.com, https://veyvora.com/peptides/mots-c-ss31-40 [3] NAD+ 1000 mg Longevity Research Pen | Veyvora, veyvora.com, https://veyvora.com/peptides/nad-1000 [4] Veyvora, research peptides, measured to the microgram, veyvora.com, https://veyvora.com/ [5] Explore Research Peptides by Focus | Veyvora, veyvora.com, https://veyvora.com/categories [6] Longevity & Cellular Research Pens | Veyvora, veyvora.com, https://veyvora.com/categories/longevity